Genomics applied to the treatment of breast cancer - Archive ouverte HAL Access content directly
Journal Articles Oncotarget Year : 2019

Genomics applied to the treatment of breast cancer

(1, 2) , (1, 3, 4) , (1, 5) , (1) , (1, 5) , (1, 6, 7)
1
2
3
4
5
6
7

Abstract

Breast cancer remains a major health issue in the world with 1.7 million new cases in 2012 worldwide. It is the second cause of death from cancer in western countries. Genomics have started to modify the treatment of breast cancer, and the developments should become more and more significant, especially in the present era of treatment personalization and with the implementation of new technologies. With molecular signatures, genomics enabled a de-escalation of chemotherapy and personalized treatments of localized forms of estrogen-dependent breast cancers. Genomics can also make a real contribution to constitutional genetics, so as to identify mutations in a panel of candidate genes. In this review, we will discuss the contributions of genomics applied to the treatment of breast cancer, whether already validated contributions or possible future applications linked to research data.
Fichier principal
Vignette du fichier
27102-1034260-1-PB.pdf (3.04 Mo) Télécharger le fichier
Loading...

Dates and versions

inserm-02545178 , version 1 (16-04-2020)

Identifiers

Cite

Diaddin Hamdan, Thi Thuy Nga Nguyen, Christophe Leboeuf, Solveig Meles, Anne Janin, et al.. Genomics applied to the treatment of breast cancer. Oncotarget, 2019, 10 (46), pp.4786-4801. ⟨10.18632/oncotarget.27102⟩. ⟨inserm-02545178⟩
233 View
60 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More